Coherentmarketinsightsus

  Chagas disease can be an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as'the kissing bugs '. Moreover, the illness may be transferred through other means such as for instance blood transfusion, organ transplantation, along with congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as for instance Europe and North America, due to migration of individuals from Latin America to others countries. For example, according a study published in National Center for Biotechnology Information (NCBI), in 2015, 4.2% of Latin American residing in European countries were chronically affected with Chagas disease. Key players operating in the Chagas Disease Treatment market include Nortec Quimica SA, Bayer AG, Laboratorio Elea Phoenix SA, Maprimed S.A., and Laboratório Farmacêutico ...